CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Debt-to-equity in % from Q1 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Charles River Laboratories International, Inc. quarterly Debt-to-equity history and growth rate from Q1 2011 to Q2 2024.
  • Charles River Laboratories International, Inc. Debt-to-equity for the quarter ending June 29, 2024 was 122 %, a 20.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 122 -30.9 -20.2% Jun 29, 2024
Q1 2024 128 -35.9 -21.9% Mar 30, 2024
Q4 2023 134 -36.4 -21.3% Dec 30, 2023
Q3 2023 141 -35.2 -20% Sep 30, 2023
Q2 2023 153 -25.7 -14.4% Jul 1, 2023
Q1 2023 164 -15.6 -8.67% Apr 1, 2023
Q4 2022 171 -8.86 -4.94% Dec 31, 2022
Q3 2022 176 +0.62 +0.35% Sep 24, 2022
Q2 2022 179 +7.33 +4.28% Jun 25, 2022
Q1 2022 180 +7.73 +4.49% Mar 26, 2022
Q4 2021 179 -4.14 -2.26% Dec 25, 2021
Q3 2021 176 -15.9 -8.28% Sep 25, 2021
Q2 2021 171 -26.8 -13.5% Jun 26, 2021
Q1 2021 172 -30.4 -15% Mar 27, 2021
Q4 2020 184 -10.7 -5.49% Dec 26, 2020
Q3 2020 192 -4.47 -2.28% Sep 26, 2020
Q2 2020 198 +1.09 +0.55% Jun 27, 2020
Q1 2020 203 +4.41 +2.23% Mar 28, 2020
Q4 2019 194 -0.83 -0.43% Dec 28, 2019
Q3 2019 196 +3.67 +1.91% Sep 28, 2019
Q2 2019 197 +10.4 +5.55% Jun 29, 2019
Q1 2019 198 +22.6 +12.9% Mar 30, 2019
Q4 2018 195 +8.59 +4.61% Dec 29, 2018
Q3 2018 193 -4.31 -2.19% Sep 29, 2018
Q2 2018 187 -17.9 -8.76% Jun 30, 2018
Q1 2018 176 -40.2 -18.6% Mar 31, 2018
Q4 2017 187 -20.1 -9.73% Dec 30, 2017
Q3 2017 197 +0.79 +0.4% Sep 30, 2017
Q2 2017 205 +14.7 +7.75% Jul 1, 2017
Q1 2017 216 +43.1 +25% Apr 1, 2017
Q4 2016 207 +31.8 +18.2% Dec 31, 2016
Q3 2016 196 +22.3 +12.8% Sep 24, 2016
Q2 2016 190 +19.7 +11.6% Jun 25, 2016
Q1 2016 173 -0.03 -0.02% Mar 26, 2016
Q4 2015 175 +12.2 +7.51% Dec 26, 2015
Q3 2015 174 +16.6 +10.6% Sep 26, 2015
Q2 2015 170 +18.9 +12.5% Jun 27, 2015
Q1 2015 173 +27.7 +19.1% Mar 28, 2015
Q4 2014 163 +12.6 +8.4% Dec 27, 2014
Q3 2014 157 +4.13 +2.7% Sep 27, 2014
Q2 2014 151 -5.15 -3.29% Jun 28, 2014
Q1 2014 145 -18.1 -11.1% Mar 29, 2014
Q4 2013 150 -20 -11.7% Dec 28, 2013
Q3 2013 153 -24.8 -14% Sep 28, 2013
Q2 2013 157 -29.5 -15.9% Jun 29, 2013
Q1 2013 163 -26.8 -14.1% Mar 30, 2013
Q4 2012 170 -27.1 -13.8% Dec 29, 2012
Q3 2012 178 -6.45 -3.5% Sep 29, 2012
Q2 2012 186 +33.9 +22.3% Jun 30, 2012
Q1 2012 190 +80.6 +73.8% Mar 31, 2012
Q4 2011 197 Dec 31, 2011
Q3 2011 184 Sep 24, 2011
Q2 2011 152 Jun 25, 2011
Q1 2011 109 Mar 26, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.